Review




Structured Review

Arrayit Corporation spotbot ii microarray printer
Comparison of USA vs. Colombia MIS-C patient samples by GCFP <t>microarray.</t> (A) Heat map of A2 serum samples comparing USA to Colombia samples. The USA patient population has a more robust signature. (B) Heat of A2 saliva samples comparing USA to Colombia samples, USA has a more robust signature.
Spotbot Ii Microarray Printer, supplied by Arrayit Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+printer+spotbot+ii/spotbot+3+microarrayer/pmc10102909-94-26-30
Average 90 stars, based on 1 article reviews
spotbot ii microarray printer - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C"

Article Title: Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C

Journal: Frontiers in Bioengineering and Biotechnology

doi: 10.3389/fbioe.2023.1066391

Comparison of USA vs. Colombia MIS-C patient samples by GCFP microarray. (A) Heat map of A2 serum samples comparing USA to Colombia samples. The USA patient population has a more robust signature. (B) Heat of A2 saliva samples comparing USA to Colombia samples, USA has a more robust signature.
Figure Legend Snippet: Comparison of USA vs. Colombia MIS-C patient samples by GCFP microarray. (A) Heat map of A2 serum samples comparing USA to Colombia samples. The USA patient population has a more robust signature. (B) Heat of A2 saliva samples comparing USA to Colombia samples, USA has a more robust signature.

Techniques Used: Comparison, Microarray

Serum from Cohorts and individual patient comparison of GCFP microarray assay to MIA. To compare a traditional MIA with the GCFP microarray, 11 analytes were included in both assays. (A) A heat map was generated by log transforming GCFP detection ratios and using the mean of each analyte detection ratio for each cohort. Of the 11 analytes, 5 were below the detection limit of the GCFP first generation biosensor chip. (B) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A1. (C) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A2. (D) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B1. (E) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B2. (F) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B3. 16 of the 44 shared serum samples had similar biomarker signatures, while IL-4, IL-6 and CCL20 were not consistently detected on the GCFP chip.
Figure Legend Snippet: Serum from Cohorts and individual patient comparison of GCFP microarray assay to MIA. To compare a traditional MIA with the GCFP microarray, 11 analytes were included in both assays. (A) A heat map was generated by log transforming GCFP detection ratios and using the mean of each analyte detection ratio for each cohort. Of the 11 analytes, 5 were below the detection limit of the GCFP first generation biosensor chip. (B) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A1. (C) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A2. (D) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B1. (E) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B2. (F) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B3. 16 of the 44 shared serum samples had similar biomarker signatures, while IL-4, IL-6 and CCL20 were not consistently detected on the GCFP chip.

Techniques Used: Comparison, Microarray, Generated, Biomarker Discovery

Related Articles

Microarray:

Article Title: Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C
Article Snippet: .. Capture antibodies were diluted to 250 μg/mL with PBS ( ) and printed on the GCFP chips using a 0.35 mm diameter microarray pin and a SpotBot II microarray printer (ArrayIt, CA, United States) or an XactII microarray printer (LabNEXT, NJ, United States). ..

Article Title: Molecular characterization of enterotoxin genes in methicillin-resistant S. aureus isolated from food poisoning outbreaks in Egypt.
Article Snippet: .. Microarray slides (Scienion, Berlin, Germany) were spotted in triplicate for each probe using The SpotBot microarrayer (ArrayIt, Sunnyvale, California, USA) spotting machine (Fig. 1). .. Each oligonucleotide solution was prepared using ArrayIt spotting buffer (ArrayIt, Sunnyvale, California, USA) in a 384-well printing plate.

other:

Article Title: Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C.
Article Snippet: Capture antibodies were diluted to 250 μg/mL with PBS (Table 1) and printed on the GCFP chips using a 0.35 mm diameter microarray pin and a SpotBot II microarray printer (ArrayIt, CA, United States) or an XactII microarray printer (LabNEXT, NJ, United States).

Article Title: Key role of PPAR-γ-mediated suppression of the NFκB signaling pathway in rutin's antidepressant effect.
Article Snippet: Background: Depression is a chronic and recurrent disorder with an unknown etiology.. Efficacious antidepressant treatments with minimal side effects are urgently needed.. Neuroinflammation may contribute to depression, as anti-inflammatory drugs have been shown to alleviate depressive symptoms in clinical practice.

Article Title: Hyperbranched polyglycerol-coated particles and methods of making and using thereof
Article Snippet: The NPs were arrayed on lysine coated slides using a SPOTBOT® microarrayer from ARRAYIT®.

Article Title: Topical formulation of hyperbranched polymer-coated particles
Article Snippet: The NPs were arrayed on lysine coated slides using a Spotbot microrrayer from Arrayit.



Similar Products

90
Arrayit Corporation spotbot ii microarray printer
Comparison of USA vs. Colombia MIS-C patient samples by GCFP <t>microarray.</t> (A) Heat map of A2 serum samples comparing USA to Colombia samples. The USA patient population has a more robust signature. (B) Heat of A2 saliva samples comparing USA to Colombia samples, USA has a more robust signature.
Spotbot Ii Microarray Printer, supplied by Arrayit Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+printer+spotbot+ii/spotbot+3+microarrayer/pmc10102909-94-26-30
Average 90 stars, based on 1 article reviews
spotbot ii microarray printer - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Arrayit Corporation microarray printer spotbot ii
Comparison of USA vs. Colombia MIS-C patient samples by GCFP <t>microarray.</t> (A) Heat map of A2 serum samples comparing USA to Colombia samples. The USA patient population has a more robust signature. (B) Heat of A2 saliva samples comparing USA to Colombia samples, USA has a more robust signature.
Microarray Printer Spotbot Ii, supplied by Arrayit Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+printer+spotbot+ii/spotbot+3+microarrayer/pm37064248-85-26-30
Average 90 stars, based on 1 article reviews
microarray printer spotbot ii - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Comparison of USA vs. Colombia MIS-C patient samples by GCFP microarray. (A) Heat map of A2 serum samples comparing USA to Colombia samples. The USA patient population has a more robust signature. (B) Heat of A2 saliva samples comparing USA to Colombia samples, USA has a more robust signature.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C

doi: 10.3389/fbioe.2023.1066391

Figure Lengend Snippet: Comparison of USA vs. Colombia MIS-C patient samples by GCFP microarray. (A) Heat map of A2 serum samples comparing USA to Colombia samples. The USA patient population has a more robust signature. (B) Heat of A2 saliva samples comparing USA to Colombia samples, USA has a more robust signature.

Article Snippet: Capture antibodies were diluted to 250 μg/mL with PBS ( ) and printed on the GCFP chips using a 0.35 mm diameter microarray pin and a SpotBot II microarray printer (ArrayIt, CA, United States) or an XactII microarray printer (LabNEXT, NJ, United States).

Techniques: Comparison, Microarray

Serum from Cohorts and individual patient comparison of GCFP microarray assay to MIA. To compare a traditional MIA with the GCFP microarray, 11 analytes were included in both assays. (A) A heat map was generated by log transforming GCFP detection ratios and using the mean of each analyte detection ratio for each cohort. Of the 11 analytes, 5 were below the detection limit of the GCFP first generation biosensor chip. (B) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A1. (C) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A2. (D) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B1. (E) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B2. (F) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B3. 16 of the 44 shared serum samples had similar biomarker signatures, while IL-4, IL-6 and CCL20 were not consistently detected on the GCFP chip.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C

doi: 10.3389/fbioe.2023.1066391

Figure Lengend Snippet: Serum from Cohorts and individual patient comparison of GCFP microarray assay to MIA. To compare a traditional MIA with the GCFP microarray, 11 analytes were included in both assays. (A) A heat map was generated by log transforming GCFP detection ratios and using the mean of each analyte detection ratio for each cohort. Of the 11 analytes, 5 were below the detection limit of the GCFP first generation biosensor chip. (B) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A1. (C) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A2. (D) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B1. (E) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B2. (F) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B3. 16 of the 44 shared serum samples had similar biomarker signatures, while IL-4, IL-6 and CCL20 were not consistently detected on the GCFP chip.

Article Snippet: Capture antibodies were diluted to 250 μg/mL with PBS ( ) and printed on the GCFP chips using a 0.35 mm diameter microarray pin and a SpotBot II microarray printer (ArrayIt, CA, United States) or an XactII microarray printer (LabNEXT, NJ, United States).

Techniques: Comparison, Microarray, Generated, Biomarker Discovery